David Ginsberg, MD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Axonics
    Date added:
    Date updated:
    04/02/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Urovant
    Date added:
    Date updated:
    04/02/2024
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Bioness
    Date added:
    Date updated:
    04/02/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Axonics
    Date added:
    Date updated:
    04/02/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Urovant
    Date added:
    Date updated:
    04/02/2024
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Bioness
    Date added:
    Date updated:
    04/02/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Axonics
    Date added:
    Date updated:
    04/02/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Urovant
    Date added:
    Date updated:
    04/02/2024
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Bioness
    Date added:
    Date updated:
    04/02/2024
Return to Webinar: Refractory OAB: Tips and Tricks on Optimal 3rd Line Therapy Delivery (2020)